$BCAX SEC Filings

Filed On	Filing
21 Oct 2026	144
07 Oct 2026	SCHEDULE 13G/A
10 Sep 2026	Form 4: Cohlhepp Ryan, Director Received 17,500 shares by exercise or conversion ($66.3K) · Sold 17,500 shares ($401K)
08 Sep 2026	144
08 Sep 2026	144
25 Aug 2026	8-K: Entry into a Material Definitive Agreement
14 Aug 2026	Form 4: Larson Jennifer, Chief Financial Officer Granted 285,000 Stock Option (Right to Buy)
14 Aug 2026	Form 3: Larson Jennifer, Chief Financial Officer No securities owned
13 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	Form 4: Hyep Ivan, Chief Financial Officer Received 12,500 shares by exercise or conversion ($47.4K) · Sold 12,500 shares ($350K)
12 Aug 2026	Form 4: Mazumdar Claire, Director Received 10,000 shares by exercise or conversion ($37.9K) · Sold 10,000 shares ($280K)
12 Aug 2026	Form 4: Cohlhepp Ryan, Director Received 18,750 shares by exercise or conversion ($71.1K) · Sold 18,750 shares ($525K)
11 Aug 2026	10-Q
11 Aug 2026	S-8
11 Aug 2026	8-K: Results of Operations and Financial Condition
10 Aug 2026	144
10 Aug 2026	144
10 Aug 2026	144
29 Jul 2026	Form 4: Bender Jeremy, Director Granted 38,950 Stock Option (Right to Buy)
29 Jul 2026	Form 4: Oliger Christy J., Director Granted 38,950 Stock Option (Right to Buy)

Comments